GHRH analog · Research compound

What is sermorelin?

A GHRH (1-29) analog — the active fragment of growth-hormone-releasing hormone — that signals the pituitary to release its own growth hormone.

Reviewed against primary literature Last updated Jun 2026 For research use only

tuned Sermorelin research vial, ≥99% purity

Purity · UPLC≥99%

In short

Sermorelin is a GHRH analog — specifically GHRH(1-29), the shortened active piece of the body's own growth-hormone-releasing hormone.[1] It binds the GHRH receptor on the pituitary and asks it to release its own growth hormone, which in turn raises IGF-1.[2] Unusually for this catalogue, it has a real regulatory history: it was an FDA-approved diagnostic and treatment (as Geref) before being withdrawn from the US market in 2008 for commercial reasons.[1]

01 — What it is

What is sermorelin, exactly?

Sermorelin is a synthetic peptide made of the first 29 amino acids of human growth-hormone-releasing hormone — written GHRH(1-29)NH₂ — which is the smallest fragment that keeps the full hormone's GH-releasing activity.[1][5]

That makes it a growth-hormone-releasing hormone analog: instead of supplying growth hormone from outside, it copies the natural upstream signal that tells the pituitary to make and release GH. It's also known as sermorelin acetate (the salt form) and historically by the brand name Geref.[1]

Is sermorelin a peptide? And what is sermorelin acetate?

Yes — sermorelin is a 29-amino-acid peptide. "Sermorelin acetate" is simply the acetate-salt form used for stability; it's the same molecule. Like other research peptides it comes as a lyophilized powder and is studied as an injectable, because the digestive tract would break the peptide down before it could work.[6]

02 — How it works

How does sermorelin work?

Sermorelin works one step upstream of growth hormone. It binds the GHRH receptor on the pituitary's somatotroph cells — the same receptor the hypothalamus uses — prompting them to release stored GH in a natural-shaped pulse, which then drives IGF-1 production in the liver.[2][5]

The GHRH-analog mechanism, and why it matters

The practical appeal of that mechanism is restraint. Because sermorelin asks the pituitary to release its own GH, the body's normal feedback brakes (somatostatin) still apply — so it tends to preserve the pulsatile rhythm of natural GH rather than overriding it the way injected GH can.[2] In healthy older men, twice-daily GHRH(1-29) was shown to reverse part of the age-related decline in GH and IGF-1,[2] which is the core mechanism behind most of sermorelin's reported uses.

03 — Benefits

Sermorelin benefits

The sermorelin benefits described in research all follow from raising the body's own GH and IGF-1 toward more youthful levels — and they are best read as research findings in specific populations, not guaranteed effects:

Restores age-lowered GH/IGF-1. Twice-daily GHRH(1-29) reversed part of the age-related fall in GH and IGF-1 in healthy older men.[2]
Body-composition interest. Longer-term GHRH-analog administration in older adults produced endocrine and metabolic effects consistent with the GH/IGF-1 axis.[3]
Diagnostic/clinical track record. It was an approved tool for assessing and treating growth-hormone deficiency, so its GH-releasing action is well-documented.[1]
Recovery & sleep interest. Because GH peaks during deep sleep, sermorelin is popular in recovery/sleep discussion — mechanism-led, not proven outcomes.

Sermorelin benefits for males and females, and results

The underlying GH/IGF-1 mechanism is not sex-specific, and the older-adult research included both men and women.[3] So "sermorelin benefits for males" and "for females" draw on the same biology; differences people report are individual, not established by sex-specific trials. As for results, the honest framing is that measured changes (IGF-1, GH pulses) are documented in studies, while the popular body-composition and "anti-aging" outcomes are extrapolations — sermorelin is not an approved treatment for them. For self-reported timelines, see the sermorelin before and after guide.

04 — Weight & metabolism

Sermorelin for weight loss

"Sermorelin for weight loss" is a common search because growth hormone has lipolytic (fat-mobilizing) effects, and restoring GH/IGF-1 in adults with low levels has metabolic consequences.[3] The reasoning is biologically real: more GH signalling can shift body composition.

Does sermorelin help with weight loss?

The honest answer is that there is no controlled sermorelin weight-loss trial establishing it as a fat-loss agent, and it is not approved for weight loss. What exists is mechanism (GH lipolysis) plus older-adult metabolic data,[3] not outcome trials in people seeking weight loss. Treat "sermorelin for weight loss" as a research-stage hypothesis, not a demonstrated result.

Growth hormone tuned Sermorelin research vial

Research-grade · ≥99% purity

tuned Sermorelin

5 MG lyophilized · batch-specific Certificate of Analysis

99% purity guaranteed

Same-day dispatch before 2 PM ET

Free shipment protection

3rd-party tested in the U.S.

View Sermorelin ▸ How we test

For laboratory research use only · available to researchers. Specifications, pricing & Certificate of Analysis on the product page.

05 — Testosterone & TRT

Sermorelin and testosterone

A frequent question is whether sermorelin raises testosterone or fits alongside testosterone replacement (TRT). The key fact: sermorelin acts on the GH/IGF-1 axis, which is biologically distinct from the gonadal (testosterone) axis. It signals the pituitary's growth-hormone cells, not the pathway that drives testosterone, so it does not directly raise testosterone.[2]

Does sermorelin increase testosterone, and sermorelin with TRT

Because the two axes are separate, sermorelin should not be expected to act as a testosterone booster. It is sometimes discussed alongside TRT in clinic and community settings — the idea being to address the GH side of age-related decline while TRT addresses the gonadal side — but pairing them is a community/clinic practice, not a validated protocol, and we present it as such, without a controlled trial behind it. We don't provide dosing or combination guidance.

06 — Dosage

Sermorelin dosage

There is no established research dose we provide for sermorelin. While it once had clinical dosing as an approved product, it is not currently a marketed US medicine, and the figures circulated in clinics and bodybuilding communities for body-composition or "anti-aging" use are not standardized clinical guidance.[1] The human GHRH-analog studies behind its mechanism used specific protocols in defined research settings.[2]

This page does not provide dosing amounts, syringe measurements, reconstitution instructions, or administration guidance — including for muscle-growth, weight-loss or bodybuilding use. Any "sermorelin dosage" figure or calculator you find online should be treated as an unverified convention rather than clinical advice.

07 — Comparison

Sermorelin vs CJC-1295

Sermorelin and CJC-1295 are both GHRH analogs — they work on the same receptor and the same "release your own GH" principle. The defining difference is duration: sermorelin is short-acting, mimicking a brief natural GHRH pulse, while CJC-1295 (especially the DAC form, which binds serum albumin) keeps the GH/IGF-1 signal elevated for far longer.[2]

Is CJC-1295 better than sermorelin?

Neither is simply "better." CJC-1295's long action means fewer, steadier exposures and a higher baseline IGF-1; sermorelin's short action stays closer to natural pulsatility, which some researchers prefer. Sermorelin also carries the stronger formal track record from its approved history.[1] A related question — "sermorelin vs MK-677" — is really GHRH analog vs an oral ghrelin-receptor secretagogue, a different mechanism entirely. For the GHRH-analog-plus-secretagogue logic, see the CJC-1295 + ipamorelin guide.

08 — Safety & identity

Is sermorelin safe?

Of the peptides in this catalogue, sermorelin has one of the better-documented safety records, precisely because it was a regulated product. In its approved use the most common adverse effects were injection-site reactions and, less often, facial flushing, headache, or transient altered taste.[1] That said, the research-chemical "sermorelin" sold to labs is not the pharmaceutical-grade Geref, and modern long-term safety data for non-approved uses are limited.

Sermorelin side effects and how to choose

Beyond the GHRH-specific effects, the GH/IGF-1 mechanism brings the usual class considerations (fluid retention, effects on glucose handling), and the theoretical caution around chronically raising IGF-1 applies to any GH-axis compound. For a fuller treatment see the sermorelin side effects guide. For choosing material, quality is the dominant variable: a batch-specific Certificate of Analysis (UPLC purity, identity, endotoxin) does more for safety than any convention. On sport, GH-axis agents are prohibited by WADA, so drug-tested athletes should treat sermorelin as banned.

Type

GHRH analog

Length

29 amino acids

Target

GHRH receptor

Drug name

Geref